DeepMind spinout Isomorphic Labs raises $5B Series C to push AI-designed drugs into clinical trials
DeepMind spinout Isomorphic Labs lands $5B Series C to take AI-designed medicines into the clinic
AI Overview
Isomorphic Labs raised a $5B Series C co-led by Greenoaks and Sequoia, six months after its $2.1B Series B.
Why it matters
The round shows how much capital AI drug discovery can absorb before any candidate reaches human trials, and it sets Isomorphic's IsoDDE platform against a growing field of rivals.